CIT - citron rho-interacting serine/threonine kinase Gene

Also Known as CITK; CRIK; STK21; MCPH17

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 11113

About CIT

Cytogenetic location: 12q24.23 Genomic coordinates (GRCh38): 12:119,685,791-119,877,320 (from NCBI)

This gene has 40 transcripts (splice variants), 272 orthologues, 5 paralogues and is associated with 3 phenotypes. Broad expression in brain (RPKM 9.1), testis (RPKM 3.2) and 18 other tissues.

Summary

This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the Kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

CIT Products (2)

mRNA Protein Name
NM_001206999.2 NP_001193928.1 citron Rho-interacting kinase isoform 1
NM_007174.3 NP_009105.1 citron Rho-interacting kinase isoform 2

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables PDZ domain binding IDA
IDA: Inferred from direct assay
17474715 GOA
enables protein binding IPI
IPI: Inferred from physical interaction
16431929 GOA
enables protein kinase binding IPI
IPI: Inferred from physical interaction
30865227 GOA
enables protein serine/threonine kinase inhibitor activity IDA
IDA: Inferred from direct assay
30865227 GOA
enables scaffold protein binding IDA
IDA: Inferred from direct assay
17474715 GOA
enables transcription coactivator binding IPI
IPI: Inferred from physical interaction
30865227 GOA
Biological Process GO Annotation Evidence References Source
involved in mitotic cytokinesis IMP
IMP: Inferred from mutant phenotype
16236794 GOA
involved in negative regulation of hippo signaling IMP
IMP: Inferred from mutant phenotype
30865227 GOA
involved in neuron apoptotic process IMP
IMP: Inferred from mutant phenotype
27453578 GOA
involved in positive regulation of cytokinesis IMP
IMP: Inferred from mutant phenotype
16431929 GOA
Cellular Component GO Annotation Evidence References Source
located in cytosol IDA
IDA: Inferred from direct assay
30865227 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CIT Protein Structure

Pkinase

Pkinase: Protein kinase domain (98 - 360)

Pkinase_C

Pkinase_C: Protein kinase C terminal domain (379 - 422)

CNH

CNH: CNH domain (1601 - 1855)

  • 0
  • 400
  • 800
  • 1200
  • 1600
  • 2027 a.a.
Protein Preferred Names Protein Names

citron Rho-interacting kinase

  • citron (rho-interacting, serine/threonine kinase 21)

Related Diseases

Diseases Alias
Microcephaly 17, Primary, Autosomal Recessive

  • MCPH17

  • Primary Autosomal Recessive Microcephaly 17
Primary Autosomal Recessive Microcephaly

  • Autosomal Recessive Primary Microcephaly

  • Mcph

  • True Microcephaly

  • Microcephalia Vera

  • Microcephaly Vera

  • Microcephaly Primary Hereditary

  • Microcephaly, Primary, Autosomal Recessive

  • Primary Microcephaly
Microcephaly 6, Primary, Autosomal Recessive

  • MCPH6

  • Primary Autosomal Recessive Microcephaly 6

  • Microcephaly, Primary Autosomal Recessive, 6

  • Microcephaly, Type 6, Primary, Autosomal Recessive
Cerebellar Hypoplasia
Microcephaly

  • Microencephaly

  • Microcephalus

  • Microcephalic

  • Nanocephaly

  • Congenital Microcephaly

  • Brain Hypoplasia

  • Brain Nondevelopment

  • Cephalic Hypoplasia

  • Undeveloped Cerebrum

  • Undeveloped Brain

  • Micrencephalon

  • Micrencephaly
Bipolar Disorder

  • Bipolar Depression

  • Manic Disorder

  • Depression, Bipolar

  • Bipolar Disorder Manic Phase

  • Depressive-Manic Psych.

  • Manic Bipolar Affective Disorder

  • Manic Bipolar I Disorder

  • Manic Depression

  • Manic Depressive Disorder

  • Mixed Bipolar Disorder

  • Bipolar Affective Disorder

  • Bipolar Affective Psychosis

  • Bipolar Spectrum Disorder

  • Manic Depressive Illness

  • Depression Bipolar

  • Bipolar Disorder, Mixed

  • Major Affective Disorder

  • Major Affective Disorder 1

  • Major Affective Disorder 2
Microcephaly 5, Primary, Autosomal Recessive

  • MCPH5

  • Primary Autosomal Recessive Microcephaly 5

  • Microcephaly Primary Autosomal Recessive 5 With Simplified Gyral Pattern

  • Microcephaly, Primary Autosomal Recessive, 5
Schizophrenia

  • SCZD

  • Schizophrenia With Or Without An Affective Disorder

  • Schizophrenia 12

  • Schizophrenia, Susceptibility To

  • Schizophrenia-1

  • Dementia Praecox

  • Schizophrenia 1
Lissencephaly

  • Pachygyria

  • Broad Gyri Of Cerebrum

  • Large Gyri Of Cerebrum

  • Macrogyria
Primary Microcephaly

  • True Microcephaly

  • Microcephaly, Primary
Congenital Nervous System Abnormality

  • Congenital Neurologic Anomaly

  • Congenital Nervous System Disorder
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99016A Enfortumab vedotin-ejfv Inhibitor 99.69% Unkown

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-160441 MC-Val-Cit-PAB-Ispinesib Inhibitor 99.85% Phase 3
HY-P99612 Farletuzumab ecteribulin 99.40% Phase 2
HY-177578 NN3201 99.15% Phase 1
HY-P4160 PDC31 Inhibitor 98.67% Phase 1
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99016B Enfortumab vedotin-ejfv (solution) Inhibitor 99.78% Phase 3

Pre-clinical Phase

Bioactive Molecules (234)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-15575 VcMMAE Inhibitor 99.97% Unkown
HY-20336 Mc-Val-Cit-PABC-PNP 98.75% Unkown
HY-100374 Val-Cit-PAB-MMAE 99.98% Unkown
HY-112786 MC-Val-Cit-PAB-MMAF 99.25% Unkown
HY-78738 MC-Val-Cit-PAB 99.88% Unkown
HY-145929 MC-Val-Cit-PAB-Exatecan Inhibitor 99.57% Unkown
HY-41189 Fmoc-Val-Cit-PAB-PNP 99.60% Unkown
HY-12362 Val-cit-PAB-OH 99.55% Unkown
HY-130990 DBCO-PEG4-Val-Cit-PAB-MMAF 98.05% Unkown
HY-15575G VcMMAE (GMP) / Unkown
HY-131296 5-A-RU-PABC-Val-Cit-Fmoc 98.98% Unkown
HY-19318 Fmoc-Val-Cit-PAB 99.75% Unkown
HY-141156 Mal-PEG8-Val-Cit-PAB-MMAE 98.10% Unkown
HY-130989 SuO-Glu-Val-Cit-PAB-MMAE 99.38% Unkown
HY-141155 endo-BCN-PEG4-Val-Cit-PAB-MMAE 98.84% Unkown
HY-139642 Mal-(CH2)5-Val-Cit-PAB-Eribulin 99.01% Unkown
HY-Y1191 EEDQ Antagonist 99.97% Unkown
HY-78736 Val-Cit-PAB-OSBT 99.85% Unkown
HY-141142 Boc-Val-Cit-PAB-PNP 99.55% Unkown
HY-141154 Amino-PEG4-Val-Cit-PAB-MMAE 99.93% Unkown
HY-W038702 Boc-Val-Cit-OH ≥98.0% Unkown
HY-141833 Bi-Mc-VC-PAB-MMAE 98.43% Unkown
HY-W008064 Fmoc-Cit-OH 99.71% Unkown
HY-100566 SuO-Val-Cit-PAB-MMAE 98.0% Unkown
HY-W591408 DBCO-Val-Cit-PAB-MMAE 98.33% Unkown
HY-130937 DBCO-Val-Cit-PABC-PNP 97.74% Unkown
HY-140145 Mal-PEG4-Val-Cit-PAB-PNP 98.48% Unkown
HY-19812 Acetylene-linker-Val-Cit-PABC-MMAE 95.07% Unkown
HY-140150 Azido-PEG3-Val-Cit-PAB-PNP 99.21% Unkown
HY-100115 TA-02 Inhibitor 99.44% Unkown
HY-148875 Py-MAA-Val-Cit-PAB-MMAE 98.46% Unkown
HY-112099 Mc-Val-Cit-PAB-Cl 95.0% Unkown
HY-128904 MC-Val-Cit-PAB-duocarmycin chloride 99.04% Unkown
HY-153031 Val-Cit-PAB-Exatecan Inhibitor 99.79% Unkown
HY-100567 MAL-di-EG-Val-Cit-PAB-MMAE 99.92% Unkown
HY-128902 MC-Val-Cit-PAB-vinblastine 99.48% Unkown
HY-141141 Boc-Val-Cit-PAB 99.86% Unkown
HY-147286 Ac-Lys-Val-Cit-PABC-MMAE 99.94% Unkown
HY-153263 (Aminooxy)acetamide-Val-Cit-PAB-MMAE 96.87% Unkown
HY-141860 PSMA-Val-Cit-PAB-MMAE 99.52% Unkown
HY-139726 Mal-PEG4-Val-Cit-PAB-MMAE 98.64% Unkown
HY-172287 DBCO-PEG2-Val-Cit-PAB-MMAE 99.27% Unkown
HY-W190943 Azido-PEG4-Val-Cit-PAB-MMAE 99.43% Unkown
HY-136154 Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP 96.67% Unkown
HY-156758 Mal-PEG8-Val-Cit-PAB-MMAF 99.97% Unkown
HY-19697 Aminocaproyl-Val-Cit-PABC-MMAE 99.89% Unkown
HY-W190927 MC-Val-Cit-Doxorubicin 99.67% Unkown
HY-112100 MC-Val-Cit-PAB-PROTAC ERα Degrader-1 Inhibitor 99.18% Unkown
HY-140014 Val-Cit 99.76% Unkown
HY-155052A PAD4-IN-2 TFA Inhibitor 95.87% Unkown
HY-44177 Val-Cit-PAB-MMAF sodium 98.97% Unkown
HY-128711 MAL-di-EG-Val-Cit-PAB-MMAF 98.56% Unkown
HY-130923 BCN-PEG1-Val-Cit-PABC-OH 95.0% Unkown
HY-138106 Fmoc-D-Cit-OH / Unkown
HY-148245 OH-Glu-Val-Cit-PAB-MMAE 99.03% Unkown
HY-153373 4A3-Cit 98.04% Unkown
HY-19813A mDPR-Val-Cit-PAB-MMAE TFA 98.36% Unkown
HY-W016733 D-Citrulline 98.0% Unkown
HY-W190913 DBCO-PEG4-Val-Cit-PAB-PNP 98.28% Unkown
HY-Z0922 (R,R)-MC-Val-Cit-PAB Control 98.1% Unkown
HY-19811 Fmoc-Val-Cit-PAB-MMAE Inhibitor 98.85% Unkown
HY-131156 Mal-PEG2-Val-Cit-PABA-PNP 95.68% Unkown
HY-15742 Vc-MMAD Inhibitor 99.79% Unkown
HY-130944 Mal-PEG1-Val-Cit-PABC-OH 95.12% Unkown
HY-136100A TCO-PEG1-Val-Cit-PABC-PNP TFA 99.69% Unkown
HY-15575S VcMMAE-d8 Inhibitor 97.56% Unkown
HY-153031A Val-Cit-PAB-Exatecan TFA Inhibitor 99.73% Unkown
HY-128908 MC-Val-Cit-PAB-Indibulin 96.58% Unkown
HY-140147 Mal-amido-PEG2-Val-Cit-PAB-PNP 98.40% Unkown
HY-147021 MC-Val-D-Cit-PAB-PNP 98.08% Unkown
HY-160774 Val-Cit-PABC-DOX Inhibitor 95.06% Unkown
HY-171931A Aminocaproyl-Val-Cit-PABC-Exatecan TFA Inhibitor 99.18% Unkown
HY-151726 Azido-PEG(4)-Val-Cit-PAB-PNP 98.05% Unkown
HY-126532 Fmoc-Val-Cit-PAB-Duocarmycin TM 99.0% Unkown
HY-126672 Mal-amide-PEG4-Val-Cit-PAB-OH 99.12% Unkown
HY-130222 Mal-PEG2-Val-Cit-PAB-OH 99.49% Unkown
HY-140144 Mal-PEG1-Val-Cit-PAB-PNP 98.41% Unkown
HY-145960A MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic Agonist 97.70% Unkown
HY-148871 Mc-Val-Cit-PAB-Gefitinib chloride 98.69% Unkown
HY-173161 Mc-d-Val-d-Cit-PAB-PNP 98.80% Unkown
HY-177599 Boc-Val-Cit-PAB-MMAE 99.72% Unkown
HY-W590556 Endo-BCN-PEG4-Val-Cit-PAB-MMAF / Unkown
HY-W947216 BCN-sulfamoyl-PEG2-sulfamoyl-bis(Val-Cit-PAB-Exatecan) / Unkown
HY-172291 Mal-amide-PEG8-Val-Cit-PAB-PNP 98.05% Unkown
HY-128899 MC-Val-Cit-PAB-Auristatin E 96.97% Unkown
HY-128906 MC-Val-Cit-PAB-Retapamulin 99.37% Unkown
HY-128909 MC-Val-Cit-PAB-rifabutin 95.33% Unkown
HY-157763 Mal-PEG1-Val-Cit-PABC-diphosphate-BTK degrader-1 Degrader / Unkown
HY-100374G Val-Cit-PAB-MMAE (GMP) / Unkown
HY-128903 MC-Val-Cit-PAB-carfilzomib iodide 95.22% Unkown
HY-128907 MC-Val-Cit-PAB-clindamycin 99.99% Unkown
HY-130966 TCO-PEG1-Val-Cit-PABC-OH 99.14% Unkown
HY-136106 Fmoc-Gly3-Val-Cit-PAB 95.0% Unkown
HY-140143 Mal-PEG4-Val-Cit-PAB-OH 96.92% Unkown
HY-140149 Azido-PEG4-Val-Cit-PAB-OH 95.09% Unkown
HY-142079 Br-C1-CONH-C5-CO-Val-Cit-PAB-MMAE / Unkown
HY-145489 Mal-PEG2-Val-Cit-PABA 98.91% Unkown
HY-145960 MC-Val-Cit-PAB-Amide-TLR7 agonist 4 Agonist 99.39% Unkown
HY-147286A Ac-Lys-Val-Cit-PABC-MMAE formic 99.96% Unkown
HY-155052 PAD4-IN-2 Inhibitor / Unkown
HY-156897 Val-Cit-amide-Ph-Maytansine 98.01% Unkown
HY-160694 cBu-Cit-GAL-02-221 Degrader / Unkown
HY-164309 DBCO-PEG3-Glu-Val-Cit-PABC-MMAE 97.69% Unkown
HY-171159 MC-Val-Cit-PAB-Sunitinib 98.25% Unkown
HY-171931 Aminocaproyl-Val-Cit-PABC-Exatecan Inhibitor / Unkown
HY-177146 Paclitaxel-MVCP / Unkown
HY-177681 N-(Mal)-N-(PEG8-Val-Cit-PAB-MMAE)-N-(PEG8-Val-Cit-PAB-Exatecan) / Unkown
HY-177683 N-(DBCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177879 2-MSP-5-HA-VA-PAB-Exatecan Inhibitor 97.96% Unkown
HY-178219 Bis-sulfone-(PEG24)-Glu-Val-Cit-PAB-MMAE 97.88% Unkown
HY-19318A Fmoc-Val-D-Cit-PAB / Unkown
HY-19318B Fmoc-D-Val-Cit-PAB / Unkown
HY-19318C Fmoc-D-Val-D-Cit-PAB 98.97% Unkown
HY-204602 Fmoc-Val-Cit-PAB-MMAF-OtBu / Unkown
HY-78738G MC-Val-Cit-PAB (GMP) / Unkown
HY-P5372A Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2 TFA Agonist 99.78% Unkown
HY-W591339 Mal-PEG8-Val-Cit-PAB-PNP 96.28% Unkown
HY-W800619 NH2-PEG4-Val-Cit-PAB-OH 99.35% Unkown
HY-185428 TRS-005 Inhibitor 99.83% Unkown
HY-126492 Vat-Cit-PAB-Monomethyl Dolastatin 10 / Unkown
HY-128893 MC-Sq-Cit-PAB-Gefitinib / Unkown
HY-128905 MC-Val-Cit-PAB-dimethylDNA31 99.97% Unkown
HY-130936 DBCO-Val-Cit-PABC-OH / Unkown
HY-101909 Val-Cit-PAB-MMAF / Unkown
HY-111121 cBu-Cit-OH / Unkown
HY-12362G Val-cit-PAB-OH (GMP) / Unkown
HY-126533 PDP-C1-Ph-Val-Cit / Unkown
HY-126667 SC-Val-Cit-PAB / Unkown
HY-126670 mDPR(Boc)-Val-Cit-PAB / Unkown
HY-126671 Mal-Phe-C4-Val-Cit-PAB / Unkown
HY-126674 Mal-Phe-C4-Val-Cit-PAB-DMEA / Unkown
HY-126676 DBCO-(PEG2-Val-Cit-PAB)2 / Unkown
HY-128894 MC-Sq-Cit-PAB-Dolastatin10 / Unkown
HY-130922 BCN-PEG1-Val-Cit-OH / Unkown
HY-130930 Acid-propionylamino-Val-Cit-OH / Unkown
HY-130934 TCO-PEG1-Val-Cit-OH / Unkown
HY-130935 DBCO-Val-Cit-OH / Unkown
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc 95.0% Unkown
HY-133459 Mal-PEG1-Val-Cit-OH / Unkown
HY-136034 Azido-PEG1-Val-Cit-OH / Unkown
HY-136098 DBCO-PEG4-acetic-Val-Cit-PAB 99.23% Unkown
HY-136100 TCO-PEG1-Val-Cit-PABC-PNP / Unkown
HY-136103 DBCO-PEG4-Propionic-Val-Cit-PAB / Unkown
HY-136105 Azido-PEG1-Val-Cit-PABC-PNP / Unkown
HY-136108 Fmoc-Gly3-Val-Cit-PAB-PNP / Unkown
HY-136137 Azide-PEG1-Val-Cit-PABC-OH / Unkown
HY-140146 Mal-amido-PEG2-Val-Cit-PAB-OH / Unkown
HY-140148 Azido-PEG3-Val-Cit-PAB-OH / Unkown
HY-141143 MC(C5)-Val-Cit / Unkown
HY-141144 OPSS-Val-Cit-PAB-OH / Unkown
HY-141145 OPSS-Val-Cit-PAB-PNP / Unkown
HY-147021A MC-D-Val-Cit-PAB-PNP / Unkown
HY-148227 Mal-Cyclobutane-1,1-dicarboxamide-Cit-PAB-MMAE / Unkown
HY-148326 Glu(OtBu)-Val-Cit-PAB-OH / Unkown
HY-151700 6-Azidohexanoyl-Val-Cit-PAB / Unkown
HY-153236 Py-MAA-Val-Cit-PAB-DX8951 / Unkown
HY-156727 Val-Cit-PABC-Ahx-May / Unkown
HY-156727A Val-Cit-PABC-Ahx-May TFA / Unkown
HY-156896 Val-Cit-amide-Cbz-N(Me)-Maytansine 97.92% Unkown
HY-158135 Val-Cit-PAB-DEA-COOH / Unkown
HY-158137 Val-Cit-PAB-DEA-Dxd / Unkown
HY-158137A Val-Cit-PAB-DEA-Dxd TFA 99.11% Unkown
HY-159797 L-Val-D-Cit-PAB / Unkown
HY-160756 Val-Cit-Exatecan Inhibitor / Unkown
HY-160756A Val-Cit-Exatecan TFA / Unkown
HY-164303 Val-Cit-PAB-DEA-Duo-DM Inhibitor / Unkown
HY-164310 TCO-PEG3-Glu-Val-Cit-PABC-MMAF Inhibitor / Unkown
HY-164346 Amine-PEG8-Val-Cit-PAB-MMAE Inhibitor / Unkown
HY-164380 MC-Val-Cit-Gly-exatecan-β-D-glucopyranosiduronic acid Ligand / Unkown
HY-172985 CIT-ALD / Unkown
HY-175881 3-Formyl-L-tyrosine-oxime-Val-Cit-PAPB / Unkown
HY-176202 TLR7/8 agonist 12-PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / Unkown
HY-177547 H-Cit-Lys(ma-Lys(PEG16))-Tyr-OH / Unkown
HY-177548 Fmoc-Val-Cit-PAB-Exatecan Inhibitor / Unkown
HY-177678 N-(Azido-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177679 N-(Amino-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177680 N-(Mal-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177682 N-(NHS-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177684 N-(endo-BCN-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177685 N-(TCO-PEG4)-N-(PEG4-Val-Cit-PAB-MMAE)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177686 N-(Azido-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177687 N-(Mal-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177688 N-(NHS-PEG4)-N-(PEG4-Val-Cit-PAB-MMAF)-N-(PEG4-Val-Cit-PAB-Exatecan) / Unkown
HY-177953 Mal-PEG2-Val-Arg-PABC-OMe-Eribulin / Unkown
HY-178489 BGC1614 / Unkown
HY-181911 L2-FK866 Inhibitor / Unkown
HY-181992 Mal-PEG4-Val-Cit-PAB-MSA-2 / Unkown
HY-184514 TPA(bi(Tos))-γ-Glu(PEG23)-Glu-Val-Cit-PAB-PNU-159682 / Unkown
HY-184739 SMP-70067-L / Unkown
HY-184740 SMP-93566-4-Leu-Cit-PAB-Glu(Ac) / Unkown
HY-185492 MC-cBu-Cit-seco-CBI dimer / Unkown
HY-186185 OSu-Val-Cit-PAB-Exa Inhibitor / Unkown
HY-19318G Fmoc-Val-Cit-PAB (GMP) / Unkown
HY-20336G Mc-Val-Cit-PABC-PNP (GMP) / Unkown
HY-78736G Val-Cit-PAB-OSBT (GMP) / Unkown
HY-N20720 Cholic acid-Cit 99.89% Unkown
HY-P10775 BT1769 Antagonist / Unkown
HY-P4007 [Pmp1,DTyr(OEt)2,Val4,Cit8] Vasopressin / Unkown
HY-P5372 Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2 Agonist / Unkown
HY-P5836 Citrullinated LL-37 1cit Inhibitor / Unkown
HY-P5837 Citrullinated LL-37 2cit Inhibitor / Unkown
HY-P5838 Citrullinated LL-37 5cit Inhibitor / Unkown
HY-P5842 Citrullinated LL-37 3cit Inhibitor / Unkown
HY-P5843 Citrullinated LL-37 4cit Inhibitor / Unkown
HY-RS02727 CIT Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03728 DHDDS Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W800626 Boc-PEG6-Val-Cit-PAB-OH / Unkown
HY-W800847 Mal-Amide-PEG4-Val-Cit-PAB-PNP / Unkown
HY-151699 6-Azidohexanoyl-Val-Cit-PAB-PNP / Unkown
HY-151709 N3-L-Cit-OH / Unkown
HY-151709A N3-L-Cit-OH DCHA / Unkown
HY-152919 Mal-amide-PEG8-Val-Cit-PAB-OH / Unkown
HY-159797A D-Val-L-Cit-PAB / Unkown
HY-164273 Azidoacetyl-Val-Cit-PAB-OH / Unkown
HY-164275 Alkyne-Val-Cit-PAB-OH / Unkown
HY-171663 Mal-Cyclobutane-1,1-dicarboxamide-Cit-PAB carbonic acid / Unkown
HY-176478 PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / Unkown
HY-177502 NHS-cBu-Cit-PAB / Unkown
HY-177503 cBu-Cit-PAB / Unkown
HY-RS16962 Cit Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23405 Cit Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W141765 Fmoc-Cit-PAB-OH 98.58% Unkown
HY-W591286 Alkyne-Val-Cit-PAB-PNP / Unkown
HY-W591440 Fmoc-Cit-PAB-PNP / Unkown
HY-W800617 NH2-PEG1-Val-Cit-PAB-OH / Unkown
HY-W800618 NH2-PEG3-Val-Cit-PAB-OH / Unkown
HY-W800620 NH2-PEG6-Val-Cit-PAB-OH / Unkown
HY-W800621 Fmoc-PEG2-Val-Cit-PAB-OH / Unkown
HY-W800622 Fmoc-PEG4-Val-Cit-PAB-OH / Unkown
HY-W800623 Fmoc-PEG6-Val-Cit-PAB-OH / Unkown
HY-W800624 Boc-PEG2-Val-Cit-PAB-OH / Unkown
HY-W800625 Boc-PEG4-Val-Cit-PAB-OH / Unkown
HY-W800814 Azido-PEG8-Amido-Val-Cit-PAB / Unkown
HY-W800837 t-Boc-N-amido-PEG4-Val-Cit / Unkown
Inhibitory Antibodies (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-164154 ADC Control Human IgG1-vcMMAF Inhibitor 97.28% Unkown
HY-P992332 CIT-013 / Unkown

Orthologs Information

Species Symbol Source ID
Rattus norvegicus CIT RGD RGD:70878
Bos taurus CIT VGNC VGNC:27375
Felis catus CIT VGNC VGNC:80432
Mus musculus CIT MGD MGI:105313
Macaca mulatta CIT VGNC VGNC:71226
Canis familiaris CIT VGNC VGNC:39282
Others CIT NCBI